The Prevalence of Migraine in Inflammatory Bowel Disease, a Systematic Review and Meta-Analysis

Overview

Journal Int J Prev Med

Date 2023 Jun 23

PMID 37351058

Authors

Hamide Olfati

Omid Mirmosayyeb

Ali Mahdi Hosseinabadi

Mahsa Ghajarzadeh

Affiliations

Soon will be listed here.

Abstract

Background: Patients with inflammatory bowel disease (IBD) suffer from a wide range of comorbidities such as migraine. In studies, the prevalence of migraine in cases with IBD was reported differently. The goal of this systematic review and meta-analysis was to estimate the pooled prevalence of migraine in IBD cases.

Methods: Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They also searched the gray literature including references of the included studies and conference abstracts which were published up to May 2021. Cross-sectional studies were included.

Results: The literature search revealed 840 articles, and after deleting duplicates, 650 remained. For the meta-analysis, 10 studies were included. Totally, 62,554 patients were evaluated. The pooled prevalence of migraine in patients with IBD was 19% (95% CI: 15-22%). The pooled prevalence of migraine in ulcerative colitis (UC) was 10% (95% CI: 4-15%) (I = 99.8%, < 0.001). The pooled prevalence of migraine in the Crohn's disease (CD) group was 24% (95% CI: 17-30%) (I = 98.8%, < 0.001). The pooled odds of developing migraine in IBD cases was 1.51 (95% CI: 1-2.27) (I = 90.8%, < 0.001).

Conclusions: The result of this systematic review and meta-analysis showed that the pooled prevalence of migraine in patients with IBD was 19% (95% CI: 15-22%).

Citing Articles

The Impact of Food Specific IgG Antibodies on Migraine and Its Comorbidities.

Zhao Z, Yang M, Zhao X, Wan F, Ning B, Zhang L Immun Inflamm Dis. 2024; 12(11):e70056.

PMID: 39552191 PMC: 11570760. DOI: 10.1002/iid3.70056.

VPAC1 and VPAC2 receptors mediate tactile hindpaw hypersensitivity and carotid artery dilatation induced by PACAP38 in a migraine relevant mouse model.

Guo S, Rasmussen R, Hay-Schmidt A, Ashina M, Asuni A, Jensen J J Headache Pain. 2024; 25(1):126.

PMID: 39085771 PMC: 11293201. DOI: 10.1186/s10194-024-01830-2.

Altered immunity in migraine: a comprehensive scoping review.

Ha W, Chu M J Headache Pain. 2024; 25(1):95.

PMID: 38844851 PMC: 11157828. DOI: 10.1186/s10194-024-01800-8.

Exploring the causal relationship between inflammatory cytokines and migraine: a bidirectional, two-sample Mendelian randomization study.

Fu C, Chen Y, Xu W, Zhang Y Sci Rep. 2023; 13(1):19394.

PMID: 37938611 PMC: 10632361. DOI: 10.1038/s41598-023-46797-3.

References

Vanmolkot F, Van Bortel L, de Hoon J . Altered arterial function in migraine of recent onset. Neurology. 2007; 68(19):1563-70. DOI: 10.1212/01.wnl.0000260964.28393.ed. View

Leitao A, Ribeiro Junior H, Araujo D, Braga L, Souza M, Barbosa A . Neuropathy and primary headaches affect different subgroups of inflammatory bowel disease patients. Neurol Sci. 2020; 42(3):935-942. DOI: 10.1007/s10072-020-04596-y. View

Chehel Cheraghi S, Ebrahimi Daryani N, Ghabaee M . A Survey on Migraine Prevalence in Patients with Inflammatory Bowel Disease - A Single Centre Experience. Middle East J Dig Dis. 2016; 8(4):282-288. PMC: 5145295. DOI: 10.15171/mejdd.2016.37. View

Buse D, Reed M, Fanning K, Bostic R, Dodick D, Schwedt T . Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020; 21(1):23. PMC: 7053108. DOI: 10.1186/s10194-020-1084-y. View

Mirmosayyeb O, Barzegar M, Nehzat N, Shaygannejad V, Sahraian M, Ghajarzadeh M . The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis. J Clin Neurosci. 2020; 79:33-38. DOI: 10.1016/j.jocn.2020.06.021. View

Hamel E . Serotonin and migraine: biology and clinical implications. Cephalalgia. 2007; 27(11):1293-300. DOI: 10.1111/j.1468-2982.2007.01476.x. View

Leira R, Sobrino T, Rodriguez-Yanez M, Blanco M, Arias S, Castillo J . Mmp-9 immunoreactivity in acute migraine. Headache. 2007; 47(5):698-702. DOI: 10.1111/j.1526-4610.2006.00641.x. View

Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M . Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study. Eur J Pain. 2017; 21(9):1550-1560. DOI: 10.1002/ejp.1056. View

Steiner T, Stovner L, Vos T, Jensen R, Katsarava Z . Migraine is first cause of disability in under 50s: will health politicians now take notice?. J Headache Pain. 2018; 19(1):17. PMC: 5821623. DOI: 10.1186/s10194-018-0846-2. View

10.

Mathieu S, Couderc M, Pereira B, Dubost J, Malochet-Guinamand S, Tournadre A . Prevalence of Migraine and Neuropathic Pain in Rheumatic Diseases. J Clin Med. 2020; 9(6). PMC: 7356241. DOI: 10.3390/jcm9061890. View

11.

Watts D, Satsangi J . The genetic jigsaw of inflammatory bowel disease. Gut. 2002; 50 Suppl 3:III31-6. PMC: 1867682. DOI: 10.1136/gut.50.suppl_3.iii31. View

12.

Elsehety A, Bertorini T . Neurologic and neuropsychiatric complications of Crohn's disease. South Med J. 1997; 90(6):606-10. DOI: 10.1097/00007611-199706000-00005. View

13.

Bahler C, Schoepfer A, Vavricka S, Brungger B, Reich O . Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland. Eur J Gastroenterol Hepatol. 2017; 29(8):916-925. DOI: 10.1097/MEG.0000000000000891. View

14.

Greenstein A, Janowitz H, Sachar D . The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976; 55(5):401-12. DOI: 10.1097/00005792-197609000-00004. View

15.

Ghersin I, Khateeb N, Katz L, Daher S, Shamir R, Assa A . Comorbidities in adolescents with inflammatory bowel disease: findings from a population-based cohort study. Pediatr Res. 2019; 87(7):1256-1262. DOI: 10.1038/s41390-019-0702-3. View

16.

Vavricka S, Schoepfer A, Scharl M, Lakatos P, Navarini A, Rogler G . Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015; 21(8):1982-92. PMC: 4511685. DOI: 10.1097/MIB.0000000000000392. View

17.

Mirmosayyeb O, Shaygannejad V, Ghajarzadeh M . Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire. J Multidiscip Healthc. 2020; 13:609-613. PMC: 7368128. DOI: 10.2147/JMDH.S260056. View

18.

Belkaid Y, Naik S . Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol. 2013; 14(7):646-53. PMC: 3845005. DOI: 10.1038/ni.2604. View

19.

Kelleci U, Calhan T, Sahin A, Kahraman R, Ozdil K, Sokmen H . The Prevalence of Headache in Crohn's Disease: Single-Center Experience. Gastroenterol Res Pract. 2016; 2016:6474651. PMC: 4745315. DOI: 10.1155/2016/6474651. View

20.

Vanmolkot F, de Hoon J . Increased C-reactive protein in young adult patients with migraine. Cephalalgia. 2007; 27(7):843-6. DOI: 10.1111/j.1468-2982.2007.01324.x. View